Search

everythinglearnresearchcommunity

for

Search:↓

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Some gonadal hormone drugs can block filovirus entry into cells.

Ritlecitinib can help about 14,000 people with severe hair loss.

Urtica fissa extract can inhibit 5α-reductase activity.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors may help skin flaps survive better by affecting nitric oxide.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.